Herbal Supplements: Talking with your Patients

Journal for Nurse Practitioners

Volumn 7, Issue 1, 2011, Pages 29-35

  Anastasi, Joyce K ^a   Chang, Michelle ^a,b   Capili, Bernadette ^a  

^a NEW YORK UNIVERSITY   (United States)

^b Division of Special Studies   (United States)

Author keywords

Botanicals; Complementary and alternative medicine; Herbal supplements; Herbs; Side effects

Indexed keywords

EID: 78650731991     PISSN: 15554155     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nurpra.2010.06.004     Document Type: Article

References (44)

1. Kennedy J, Wang CC, Wu CH Patient disclosure about herb and supplement use among adults in the US. Evid Based Complement Alternat Med 2008, 5:451-456.
2. Cavaliere C, Rea P, Lynch ME, Blumenthal M Herbal supplement sales rise in all channels in 2009. Herbalgram 2010, 86:62-65.
3. Pettigrew AC, King MO, McGee K, Rudolph C Complementary therapy use by women's health clinic clients. Alternat Therap Health Med 2004, 10(6):50-55.
4. US Government Accountability Office. Herbal Dietary Supplements: Examples of Deceptive or Questionable Marketing Practices and Potentially Dangerous Advice. Publication No. GAO-10-662T May 26, 2010. Accessed June 9, 2010.
5. Shord SS, Shah K, Lukose A Drug-Botanical Interactions: A review of the laboratory, animal, and human data for 8 common botanicals. Integrative Cancer Therap 2009, 8(3):208-227.
6. Gardner CD, Lawson LD, Block E, et al. Effect of raw garlic vs commercial garlic supplements on plasma lipid concentrations in adults with moderate hypercholesterolemia: a randomized clinical trial. Arch Intern Med 2007, 167:346-353.
7. Reinhart KM, Coleman CI, Teevan C, et al. Effects of garlic on blood pressure in patients with and without systolic hypertension: a meta-analysis. Ann Pharmacother 2008, 42(12):1766-1771.
8. Fleischauer AT, Poole C, Arab L Garlic consumption and cancer prevention: meta-analyses of colorectal and stomach cancers. Am J Clin Nutr 2000, 72(4):1047-1052.
9. Izzo AA, Ernst E Interactions between herbal medicines and prescribed drugs: an updated systematic review. Drugs 2009, 69(13):1777-1798.
10. Wilt TJ, Ishani A, Stark G, et al. Saw palmetto extracts for treatment of benign prostatic hyperplasia: a systematic review. JAMA 1998, 280:1604-1609.
11. Gerber GS, Kuznetsov D, Johnson BC, Burstein JD Randomized, double-blind, placebo-controlled trial of saw palmetto in men with lower urinary tract symptoms. Urology 2001, 58(6):960-965.
12. Tacklind J, MacDonald R, Rutks I, Wilt TJ Serenoa repens for benign prostatic hyperplasia. Cochrane Database of Systematic Reviews 2009, 2:CD001423. 10.1002/14651858.CD001423.pub2.
13. Avins AL, Bent S, Staccone S, et al. A detailed safety assessment of a saw palmetto extract. Complement Ther Med 2008, 16(3):147-154.
14. DeFeudis FV, Drieu K Ginkgo biloba extract (EGb 761) and CNS functions: basic studies and clinical applications. Curr Drug Targets 2000, 1(1):25-58.
15. LeBars PL, et al. A placebo-controlled double-blind randomized trial of an extract of ginkgo biloba for dementia. JAMA 1997, 278:1327-1332.
16. DeKosky ST, Williamson JD, Fitzpatrick AL, et al. Ginkgo biloba for prevention of dementia. JAMA 2008, 300(19):2253-2262.
17. Snitz BE, O'Meara ES, Carlson MC, et al. Ginkgo biloba for preventing cognitive decline in older adults: a randomized trial. JAMA 2009, 302(24):2663-2670.
18. Kuller LH, Ives DG, Fitzpatrick AL, et al. Does ginkgo biloba reduce the risk of cardiovascular events?. Circ Cardiovasc Qual Outcomes 2010, 3:41-47.
19. Shah SA, Sander S, White CM, et al. Evaluation of Echinacea for the prevention and treatment of the common cold: a meta-analysis. Lancet Infect Dis 2007, 7:473-480.
20. Ladas EJ, Kroll DJ, Oberlies NH, et al. A randomized, controlled, double-blind, pilot study of milk thistle for the treatment of hepatotoxicity in childhood acute lymphoblastic leukemia (ALL). Cancer 2010, 116:506-513.
21. Tamayo C, Diamond S Review of clinical trials evaluating safety and efficacy of milk thistle (Silybum marianum [L.] Gaertn.). Integrative Cancer Therapies 2007, 6(2):146-157.
22. Fava M, Alpert J, Nierenberg AA, et al. A double-blind, randomized trial of St John's wort, fluoxetine, and placebo in major depressive disorder. J Clin Psychopharm 2005, 25(5):441-447.
23. Linde K, Berner MM, Kriston L St. John's wort for major depression. Cochrane Database of Systematic Reviews 2008, (4). Art No.: CD000448. 10.1002/14651858.CD000448.pub3.
24. Borrelli F, Izzo AA Herb-drug interactions with St. John's wort (hypericum perforatum): an update on clinical observations. AAPS J 2009, 11(4):710-727.
25. Vuksan V, Stavro MP, Sievenpiper JL, et al. Similar postprandial glycemic reductions with escalation of dose and administration time of American ginseng in type 2 diabetes. Diabetes Care 2000, 23(9):1221-1226.
26. Seida JK, Durec T, Kuhle S North American (Panax quinquefolius) and Asian ginseng (Panax ginseng) preparations for prevention of the common cold in healthy adults: a systematic review. Evid Based Complement Alternat Med 2009 Jul 10, 10.1093/ecam/nep068.
27. Barton DL, Soori GS, Bauer BA, et al. Pilot study of Panax quinquefolius (American ginseng) to improve cancer-related fatigue: a randomized, double-blind, dose-finding evaluation: NCCTG trial N03CA. Support Care Cancer 2010, 18:179-187.
28. Yuan CS, Wei G, Dey L, et al. Brief communication: American ginseng reduces warfarin's effect in healthy patients- a randomized, controlled trial. Ann Intern Med 2004, 141:23-27.
29. Rotem C, Kaplan B Phyto-female complex for the relief of hot flushes, night sweats and quality of sleep: randomized, controlled, double blind pilot study. Gynecol Endocrinol 2007, 23(2):117-122.
30. Sammartino A, Tommaselli GA, Gargano V, et al. Short term effects of a combination of isoflavones, lignans and cimicifuga racemosa on climacteric-related symptoms in postmenopausal women: a double blind, randomized, placebo controlled trial. Gynecol Endocrinol 2006, 22(11):646-650.
31. Geller SE, Shulman LP, van Breemen RB, et al. Safety and efficacy of black cohosh and red clover for the management of vasomotor symptoms: a randomized controlled trial. Menopause 2009, 16(6):1156-1166.
32. Newton KM, Reed SD, LaCroix AZ, et al. Treatment of vasomotor symptoms of menopause with black cohosh, multibotanicals, soy, hormone therapy, or placebo: a randomized trial. Ann Intern Med 2006, 145(12):869-879.
33. Uebelhack R, Blohmer JU, Graubaum HJ, et al. Black cohosh and St. John's wort for climacteric complaints: a randomized trial. Obstet Gynecol 2006, 107:247-255.
34. Teschke R Black cohosh and suspected hepatotoxicity: inconsistencies, confounding variables, and prospective use of a diagnostic causality algorithm. A critical review. Menopause 2010, 17(2):426-440.
35. Rockwell S, Liu Y, Higgins SA Alteration of the effects of cancer therapy agents on breast cancer cells by the herbal medicine black cohosh. Breast Cancer Res Treatment 2005, 90(3):233-239.
36. Vinson JA, Teufel K, Wu N Green and black teas inhibit atherosclerosis by lipid, antioxidant, and fibrinolytic mechanisms. J Agric Food Chem 2004, 52:3661-3665.
37. Maron DJ, Lu GP, Cai NS, et al. Cholesterol-lowering effect of a theaflavin-enriched green tea extract: A randomized controlled trial. Arch Intern Med 2003, 163:1448-1453.
38. Kuriyama S, Shimazu T, Ohmori K, et al. Green tea consumption and mortality due to cardiovascular disease, cancer, and all causes in Japan. JAMA 2006, 296:1255-1265.
39. Boehm K, Borrelli F, Ernst E, et al. Green tea (camellia sinensis) for the prevention of cancer. Cochrane Database of Systematic Reviews 2009, 3:CD005004. 10.1002/14651858.CD005004.pub2.
40. Jimenez-Saenz M, Martinez-Sanchez MC Acute hepatitis associated with ingestion of green tea infusions. J Hepatology 2006, 44:616-617.
41. Golden EB, Lam PY, Kardosh A, et al. Green tea polyphenols block the anticancer effects of bortezomib and other boronic acid-based proteasome inhibitors. Blood 2009, 113:5927-5937.
42. Fernandez San Martin MI, Masa-Font R, Palacios-Soler L, et al. Effectiveness of valerian on insomnia: A meta-analysis of randomized placebo controlled trials. Sleep Medicine 2010, 11(6):505-511.
43. Donovan JL, DeVane CL, Chavin KD, et al. Multiple night time doses of valerian had minimal effects on CYP3A4 activity and no effect on CYP2D6 activity in healthy volunteers. Drug Metabol Dispos 2004, 32(12):1333-1336.
44. Taibi DM, Landis CA, Petry H, Vitiello MV A systematic review of valerian as a sleep aid: safe but not effective. Sleep Medicine Reviews 2007, 11:209-230.